A carregar...
Dipeptidyl peptidase 4 inhibitor anagliptin ameliorates hypercholesterolemia in hypercholesterolemic mice through inhibition of intestinal cholesterol transport
AIMS/INTRODUCTION: Recent data showed that dipeptidyl peptidase 4 (DPP‐4) inhibitors exert a lipid‐lowering effect in diabetes patients. However, the mechanism of action is not yet clearly understood. We investigated the effect of anagliptin on cholesterol metabolism and transport in the small intes...
Na minha lista:
| Publicado no: | J Diabetes Investig |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6215941/ https://ncbi.nlm.nih.gov/pubmed/29754453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12860 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|